-transparent.png){kind=logo}
Sheng-Mai-San (SMS), a traditional Chinese formulation used for the treatment of coronary heart disease, is comprised of Radix Ginseng, Fructus Schisandrae and Radix Ophiopogonis. Pretreatment with a lignan-enriched SMS (17 g/kg/day x 3, p.o.) was found effective in protection against isoproterenol-induced myocardial injury in rats, and in ischemia-reperfusion injury in isolated perfused hearts prepared from pretreated animals. Results obtained from pretreatment studies using extracts prepared by mixing various combinations of the three component herbs indicate that the major myocardial protective component in SMS is the lignan-enriched extract of Fructus Schisandrae.
Related Publications
P C Li, and
K T Poon, and
K M Ko
October 2013,
Pharmaceutical biology,
P C Li, and
K T Poon, and
K M Ko
January 2006,
The American journal of Chinese medicine,
P C Li, and
K T Poon, and
K M Ko
August 2002,
Circulation journal : official journal of the Japanese Circulation Society,
P C Li, and
K T Poon, and
K M Ko
June 1988,
Zhonghua yi xue za zhi,
P C Li, and
K T Poon, and
K M Ko
December 1994,
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine,
P C Li, and
K T Poon, and
K M Ko
January 2016,
Evidence-based complementary and alternative medicine : eCAM,
P C Li, and
K T Poon, and
K M Ko
May 1991,
Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine,
P C Li, and
K T Poon, and
K M Ko
November 2019,
BMC complementary and alternative medicine,
P C Li, and
K T Poon, and
K M Ko
August 1989,
Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine,
P C Li, and
K T Poon, and
K M Ko
March 1982,
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan,
